Featured Article

International research collaboration reveals promising drug candidate for treatment of blood cancers

Today, OncoTartis, Inc. and Children’s Cancer Institute jointly announced the publication of two research manuscripts in a leading onco-haematological journal Leukemia, both devoted to...

International research collaboration reveals promising drug candidate for treatment of blood cancers

January 16, 2020

An international research collaboration between the United States and Australia has revealed a promising new drug which could treat high-risk leukaemia.

New therapy shows ‘dramatic’ effect against worst leukaemias

December 10, 2019

A collaborative research effort by Australian and US scientists has led to the discovery of a promising new approach to treating some of the worst types of leukaemia, including an aggressive leukaemia that mostly affects babies.

Researchers find new way to target childhood cancer

November 18, 2019

An Australian-led international research effort has broken fresh ground in the race to find more effective treatments for the childhood cancer neuroblastoma.

Children’s Cancer Institute welcome the Governor-General and Linda Hurley as Patrons

September 4, 2019

Children’s Cancer Institute is pleased to welcome His Excellency General the Honourable David Hurley AC DSC (Retd), Governor-General of Australia and Mrs Hurley as Patrons.

New gene found for a deadly childhood cancer offers possibility of targeted drug therapy

July 31, 2019

Australian researchers from Children’s Cancer Institute have discovered a gene that plays an important role in the childhood cancer neuroblastoma, and have developed a targeted therapy against it.

Australian researchers find chink in the armour of one of the most aggressive leukaemia types

July 28, 2019

A team from Children's Cancer Institute has found a drug that offers new hope to infants with one of the most aggressive forms of leukaemia.

New research paves the way for safer leukaemia treatments

May 30, 2019

An international team of researchers has discovered a new and much safer way to treat a type of leukaemia that mainly affects children: T-cell acute lymphoblastic leukemia (T-ALL).

Minderoo Foundation’s $5 million donation to Zero Childhood Cancer will help kids like Jack beat brain cancer

May 15, 2019

Today Minderoo Foundation’s Eliminate Cancer initiative announced a $5 million partnership with Zero to help scale the program in Australia, drive further research into personalised medicine in childhood cancer and help established standardised international protocols.

Childhood cancer scientist rewarded for research excellence

April 1, 2019

Children’s Cancer Institute researcher Professor Maria Kavallaris AM – who in January this year was appointed a Member of the Order of Australia for her significant service to medicine and to medical research – today received further recognition for her work, winning the prestigious Lemberg Medal.

Leading children’s cancer scientist awarded for outstanding research

March 15, 2019

Professor Murray Norris AM, Deputy Director of Children’s Cancer Institute and Director of the Centre for Childhood Cancer Research at the University of New South Wales, has won the inaugural Sally Crossing AM Award for an Outstanding Outcome in Cancer Research.

World-Class Comprehensive Children’s Cancer Centre Announced

March 1, 2019

State and Commonwealth Health Ministers, Brad Hazzard and Greg Hunt, announce that a new, world-class Comprehensive Children’s Cancer Centre will be built on the Randwick Hospital Campus, as a new home for Children’s Cancer Institute, and also for an expanded Kid’s Cancer Centre at Sydney Children’s Hospital.

Australian Scientists Discover a Potential Way to Treat and Prevent Cancer in Children with Neuroblastoma

February 1, 2019

In new research published this week, a team jointly led by Professors Michelle Haber and Murray Norris has revealed that the polyamine pathway is entirely regulated by the MYCN oncogene

Maria Kavallaris receives Order of Australia

January 26, 2019

Children’s Cancer Institute is thrilled to announce that Professor Maria Kavallaris – a leading childhood cancer researcher and a pioneer of nanomedicine in Australia – is to be appointed a Member of the Order of Australia. She will be included in the 2019 Australia Day Honours List for her significant service to medicine, and to medical research, in the field of childhood and adult cancers.

For children with the most common childhood cancer, resistance to treatment has remained an enigma – until now

December 17, 2018

Research published last week in the prestigious journal, Cancer Cell, by scientists at Children’s Cancer Institute in Sydney, has discovered why one of the most successful classes of drugs used to treat acute lymphoblastic leukaemia (ALL), glucocorticoids, fails to work in 15% of children with the disease.

How Targeting Copper Levels in Tumours Could Hold Key to One of the Deadliest Childhood Cancers

November 19, 2018

Tumour cells are known to have high levels of copper. Now researchers at Children’s Cancer Institute in Sydney have found that an antioxidant found in green tea can kill tumour cells by targeting only those with high levels of the metal without harming the healthy cells around them.


International research collaboration reveals promising drug candidate for treatment of blood cancers

January 16, 2020

An international research collaboration between the United States and Australia has revealed a promising new drug which could treat high-risk leukaemia.

New therapy shows ‘dramatic’ effect against worst leukaemias

December 10, 2019

A collaborative research effort by Australian and US scientists has led to the discovery of a promising new approach to treating some of the worst types of leukaemia, including an aggressive leukaemia that mostly affects babies.

Researchers find new way to target childhood cancer

November 18, 2019

An Australian-led international research effort has broken fresh ground in the race to find more effective treatments for the childhood cancer neuroblastoma.

Children’s Cancer Institute welcome the Governor-General and Linda Hurley as Patrons

September 4, 2019

Children’s Cancer Institute is pleased to welcome His Excellency General the Honourable David Hurley AC DSC (Retd), Governor-General of Australia and Mrs Hurley as Patrons.

New gene found for a deadly childhood cancer offers possibility of targeted drug therapy

July 31, 2019

Australian researchers from Children’s Cancer Institute have discovered a gene that plays an important role in the childhood cancer neuroblastoma, and have developed a targeted therapy against it.

Australian researchers find chink in the armour of one of the most aggressive leukaemia types

July 28, 2019

A team from Children's Cancer Institute has found a drug that offers new hope to infants with one of the most aggressive forms of leukaemia.

New research paves the way for safer leukaemia treatments

May 30, 2019

An international team of researchers has discovered a new and much safer way to treat a type of leukaemia that mainly affects children: T-cell acute lymphoblastic leukemia (T-ALL).

Minderoo Foundation’s $5 million donation to Zero Childhood Cancer will help kids like Jack beat brain cancer

May 15, 2019

Today Minderoo Foundation’s Eliminate Cancer initiative announced a $5 million partnership with Zero to help scale the program in Australia, drive further research into personalised medicine in childhood cancer and help established standardised international protocols.

Childhood cancer scientist rewarded for research excellence

April 1, 2019

Children’s Cancer Institute researcher Professor Maria Kavallaris AM – who in January this year was appointed a Member of the Order of Australia for her significant service to medicine and to medical research – today received further recognition for her work, winning the prestigious Lemberg Medal.

Leading children’s cancer scientist awarded for outstanding research

March 15, 2019

Professor Murray Norris AM, Deputy Director of Children’s Cancer Institute and Director of the Centre for Childhood Cancer Research at the University of New South Wales, has won the inaugural Sally Crossing AM Award for an Outstanding Outcome in Cancer Research.

World-Class Comprehensive Children’s Cancer Centre Announced

March 1, 2019

State and Commonwealth Health Ministers, Brad Hazzard and Greg Hunt, announce that a new, world-class Comprehensive Children’s Cancer Centre will be built on the Randwick Hospital Campus, as a new home for Children’s Cancer Institute, and also for an expanded Kid’s Cancer Centre at Sydney Children’s Hospital.

Australian Scientists Discover a Potential Way to Treat and Prevent Cancer in Children with Neuroblastoma

February 1, 2019

In new research published this week, a team jointly led by Professors Michelle Haber and Murray Norris has revealed that the polyamine pathway is entirely regulated by the MYCN oncogene

Maria Kavallaris receives Order of Australia

January 26, 2019

Children’s Cancer Institute is thrilled to announce that Professor Maria Kavallaris – a leading childhood cancer researcher and a pioneer of nanomedicine in Australia – is to be appointed a Member of the Order of Australia. She will be included in the 2019 Australia Day Honours List for her significant service to medicine, and to medical research, in the field of childhood and adult cancers.

For children with the most common childhood cancer, resistance to treatment has remained an enigma – until now

December 17, 2018

Research published last week in the prestigious journal, Cancer Cell, by scientists at Children’s Cancer Institute in Sydney, has discovered why one of the most successful classes of drugs used to treat acute lymphoblastic leukaemia (ALL), glucocorticoids, fails to work in 15% of children with the disease.

How Targeting Copper Levels in Tumours Could Hold Key to One of the Deadliest Childhood Cancers

November 19, 2018

Tumour cells are known to have high levels of copper. Now researchers at Children’s Cancer Institute in Sydney have found that an antioxidant found in green tea can kill tumour cells by targeting only those with high levels of the metal without harming the healthy cells around them.


International research collaboration reveals promising drug candidate for treatment of blood cancers

January 16, 2020

An international research collaboration between the United States and Australia has revealed a promising new drug which could treat high-risk leukaemia.

New therapy shows ‘dramatic’ effect against worst leukaemias

December 10, 2019

A collaborative research effort by Australian and US scientists has led to the discovery of a promising new approach to treating some of the worst types of leukaemia, including an aggressive leukaemia that mostly affects babies.

Researchers find new way to target childhood cancer

November 18, 2019

An Australian-led international research effort has broken fresh ground in the race to find more effective treatments for the childhood cancer neuroblastoma.

Children’s Cancer Institute welcome the Governor-General and Linda Hurley as Patrons

September 4, 2019

Children’s Cancer Institute is pleased to welcome His Excellency General the Honourable David Hurley AC DSC (Retd), Governor-General of Australia and Mrs Hurley as Patrons.

New gene found for a deadly childhood cancer offers possibility of targeted drug therapy

July 31, 2019

Australian researchers from Children’s Cancer Institute have discovered a gene that plays an important role in the childhood cancer neuroblastoma, and have developed a targeted therapy against it.

Australian researchers find chink in the armour of one of the most aggressive leukaemia types

July 28, 2019

A team from Children's Cancer Institute has found a drug that offers new hope to infants with one of the most aggressive forms of leukaemia.

New research paves the way for safer leukaemia treatments

May 30, 2019

An international team of researchers has discovered a new and much safer way to treat a type of leukaemia that mainly affects children: T-cell acute lymphoblastic leukemia (T-ALL).

Minderoo Foundation’s $5 million donation to Zero Childhood Cancer will help kids like Jack beat brain cancer

May 15, 2019

Today Minderoo Foundation’s Eliminate Cancer initiative announced a $5 million partnership with Zero to help scale the program in Australia, drive further research into personalised medicine in childhood cancer and help established standardised international protocols.

Childhood cancer scientist rewarded for research excellence

April 1, 2019

Children’s Cancer Institute researcher Professor Maria Kavallaris AM – who in January this year was appointed a Member of the Order of Australia for her significant service to medicine and to medical research – today received further recognition for her work, winning the prestigious Lemberg Medal.

Leading children’s cancer scientist awarded for outstanding research

March 15, 2019

Professor Murray Norris AM, Deputy Director of Children’s Cancer Institute and Director of the Centre for Childhood Cancer Research at the University of New South Wales, has won the inaugural Sally Crossing AM Award for an Outstanding Outcome in Cancer Research.

World-Class Comprehensive Children’s Cancer Centre Announced

March 1, 2019

State and Commonwealth Health Ministers, Brad Hazzard and Greg Hunt, announce that a new, world-class Comprehensive Children’s Cancer Centre will be built on the Randwick Hospital Campus, as a new home for Children’s Cancer Institute, and also for an expanded Kid’s Cancer Centre at Sydney Children’s Hospital.

Australian Scientists Discover a Potential Way to Treat and Prevent Cancer in Children with Neuroblastoma

February 1, 2019

In new research published this week, a team jointly led by Professors Michelle Haber and Murray Norris has revealed that the polyamine pathway is entirely regulated by the MYCN oncogene

Maria Kavallaris receives Order of Australia

January 26, 2019

Children’s Cancer Institute is thrilled to announce that Professor Maria Kavallaris – a leading childhood cancer researcher and a pioneer of nanomedicine in Australia – is to be appointed a Member of the Order of Australia. She will be included in the 2019 Australia Day Honours List for her significant service to medicine, and to medical research, in the field of childhood and adult cancers.

For children with the most common childhood cancer, resistance to treatment has remained an enigma – until now

December 17, 2018

Research published last week in the prestigious journal, Cancer Cell, by scientists at Children’s Cancer Institute in Sydney, has discovered why one of the most successful classes of drugs used to treat acute lymphoblastic leukaemia (ALL), glucocorticoids, fails to work in 15% of children with the disease.

How Targeting Copper Levels in Tumours Could Hold Key to One of the Deadliest Childhood Cancers

November 19, 2018

Tumour cells are known to have high levels of copper. Now researchers at Children’s Cancer Institute in Sydney have found that an antioxidant found in green tea can kill tumour cells by targeting only those with high levels of the metal without harming the healthy cells around them.


International research collaboration reveals promising drug candidate for treatment of blood cancers

January 16, 2020

An international research collaboration between the United States and Australia has revealed a promising new drug which could treat high-risk leukaemia.

New therapy shows ‘dramatic’ effect against worst leukaemias

December 10, 2019

A collaborative research effort by Australian and US scientists has led to the discovery of a promising new approach to treating some of the worst types of leukaemia, including an aggressive leukaemia that mostly affects babies.

Researchers find new way to target childhood cancer

November 18, 2019

An Australian-led international research effort has broken fresh ground in the race to find more effective treatments for the childhood cancer neuroblastoma.

Children’s Cancer Institute welcome the Governor-General and Linda Hurley as Patrons

September 4, 2019

Children’s Cancer Institute is pleased to welcome His Excellency General the Honourable David Hurley AC DSC (Retd), Governor-General of Australia and Mrs Hurley as Patrons.

New gene found for a deadly childhood cancer offers possibility of targeted drug therapy

July 31, 2019

Australian researchers from Children’s Cancer Institute have discovered a gene that plays an important role in the childhood cancer neuroblastoma, and have developed a targeted therapy against it.

Australian researchers find chink in the armour of one of the most aggressive leukaemia types

July 28, 2019

A team from Children's Cancer Institute has found a drug that offers new hope to infants with one of the most aggressive forms of leukaemia.

New research paves the way for safer leukaemia treatments

May 30, 2019

An international team of researchers has discovered a new and much safer way to treat a type of leukaemia that mainly affects children: T-cell acute lymphoblastic leukemia (T-ALL).

Minderoo Foundation’s $5 million donation to Zero Childhood Cancer will help kids like Jack beat brain cancer

May 15, 2019

Today Minderoo Foundation’s Eliminate Cancer initiative announced a $5 million partnership with Zero to help scale the program in Australia, drive further research into personalised medicine in childhood cancer and help established standardised international protocols.

Childhood cancer scientist rewarded for research excellence

April 1, 2019

Children’s Cancer Institute researcher Professor Maria Kavallaris AM – who in January this year was appointed a Member of the Order of Australia for her significant service to medicine and to medical research – today received further recognition for her work, winning the prestigious Lemberg Medal.

Leading children’s cancer scientist awarded for outstanding research

March 15, 2019

Professor Murray Norris AM, Deputy Director of Children’s Cancer Institute and Director of the Centre for Childhood Cancer Research at the University of New South Wales, has won the inaugural Sally Crossing AM Award for an Outstanding Outcome in Cancer Research.

World-Class Comprehensive Children’s Cancer Centre Announced

March 1, 2019

State and Commonwealth Health Ministers, Brad Hazzard and Greg Hunt, announce that a new, world-class Comprehensive Children’s Cancer Centre will be built on the Randwick Hospital Campus, as a new home for Children’s Cancer Institute, and also for an expanded Kid’s Cancer Centre at Sydney Children’s Hospital.

Australian Scientists Discover a Potential Way to Treat and Prevent Cancer in Children with Neuroblastoma

February 1, 2019

In new research published this week, a team jointly led by Professors Michelle Haber and Murray Norris has revealed that the polyamine pathway is entirely regulated by the MYCN oncogene

Maria Kavallaris receives Order of Australia

January 26, 2019

Children’s Cancer Institute is thrilled to announce that Professor Maria Kavallaris – a leading childhood cancer researcher and a pioneer of nanomedicine in Australia – is to be appointed a Member of the Order of Australia. She will be included in the 2019 Australia Day Honours List for her significant service to medicine, and to medical research, in the field of childhood and adult cancers.

For children with the most common childhood cancer, resistance to treatment has remained an enigma – until now

December 17, 2018

Research published last week in the prestigious journal, Cancer Cell, by scientists at Children’s Cancer Institute in Sydney, has discovered why one of the most successful classes of drugs used to treat acute lymphoblastic leukaemia (ALL), glucocorticoids, fails to work in 15% of children with the disease.

How Targeting Copper Levels in Tumours Could Hold Key to One of the Deadliest Childhood Cancers

November 19, 2018

Tumour cells are known to have high levels of copper. Now researchers at Children’s Cancer Institute in Sydney have found that an antioxidant found in green tea can kill tumour cells by targeting only those with high levels of the metal without harming the healthy cells around them.


International research collaboration reveals promising drug candidate for treatment of blood cancers

January 16, 2020

An international research collaboration between the United States and Australia has revealed a promising new drug which could treat high-risk leukaemia.

New therapy shows ‘dramatic’ effect against worst leukaemias

December 10, 2019

A collaborative research effort by Australian and US scientists has led to the discovery of a promising new approach to treating some of the worst types of leukaemia, including an aggressive leukaemia that mostly affects babies.

Researchers find new way to target childhood cancer

November 18, 2019

An Australian-led international research effort has broken fresh ground in the race to find more effective treatments for the childhood cancer neuroblastoma.

Children’s Cancer Institute welcome the Governor-General and Linda Hurley as Patrons

September 4, 2019

Children’s Cancer Institute is pleased to welcome His Excellency General the Honourable David Hurley AC DSC (Retd), Governor-General of Australia and Mrs Hurley as Patrons.

New gene found for a deadly childhood cancer offers possibility of targeted drug therapy

July 31, 2019

Australian researchers from Children’s Cancer Institute have discovered a gene that plays an important role in the childhood cancer neuroblastoma, and have developed a targeted therapy against it.

Australian researchers find chink in the armour of one of the most aggressive leukaemia types

July 28, 2019

A team from Children's Cancer Institute has found a drug that offers new hope to infants with one of the most aggressive forms of leukaemia.

New research paves the way for safer leukaemia treatments

May 30, 2019

An international team of researchers has discovered a new and much safer way to treat a type of leukaemia that mainly affects children: T-cell acute lymphoblastic leukemia (T-ALL).

Minderoo Foundation’s $5 million donation to Zero Childhood Cancer will help kids like Jack beat brain cancer

May 15, 2019

Today Minderoo Foundation’s Eliminate Cancer initiative announced a $5 million partnership with Zero to help scale the program in Australia, drive further research into personalised medicine in childhood cancer and help established standardised international protocols.

Childhood cancer scientist rewarded for research excellence

April 1, 2019

Children’s Cancer Institute researcher Professor Maria Kavallaris AM – who in January this year was appointed a Member of the Order of Australia for her significant service to medicine and to medical research – today received further recognition for her work, winning the prestigious Lemberg Medal.

Leading children’s cancer scientist awarded for outstanding research

March 15, 2019

Professor Murray Norris AM, Deputy Director of Children’s Cancer Institute and Director of the Centre for Childhood Cancer Research at the University of New South Wales, has won the inaugural Sally Crossing AM Award for an Outstanding Outcome in Cancer Research.

World-Class Comprehensive Children’s Cancer Centre Announced

March 1, 2019

State and Commonwealth Health Ministers, Brad Hazzard and Greg Hunt, announce that a new, world-class Comprehensive Children’s Cancer Centre will be built on the Randwick Hospital Campus, as a new home for Children’s Cancer Institute, and also for an expanded Kid’s Cancer Centre at Sydney Children’s Hospital.

Australian Scientists Discover a Potential Way to Treat and Prevent Cancer in Children with Neuroblastoma

February 1, 2019

In new research published this week, a team jointly led by Professors Michelle Haber and Murray Norris has revealed that the polyamine pathway is entirely regulated by the MYCN oncogene

Maria Kavallaris receives Order of Australia

January 26, 2019

Children’s Cancer Institute is thrilled to announce that Professor Maria Kavallaris – a leading childhood cancer researcher and a pioneer of nanomedicine in Australia – is to be appointed a Member of the Order of Australia. She will be included in the 2019 Australia Day Honours List for her significant service to medicine, and to medical research, in the field of childhood and adult cancers.

For children with the most common childhood cancer, resistance to treatment has remained an enigma – until now

December 17, 2018

Research published last week in the prestigious journal, Cancer Cell, by scientists at Children’s Cancer Institute in Sydney, has discovered why one of the most successful classes of drugs used to treat acute lymphoblastic leukaemia (ALL), glucocorticoids, fails to work in 15% of children with the disease.

How Targeting Copper Levels in Tumours Could Hold Key to One of the Deadliest Childhood Cancers

November 19, 2018

Tumour cells are known to have high levels of copper. Now researchers at Children’s Cancer Institute in Sydney have found that an antioxidant found in green tea can kill tumour cells by targeting only those with high levels of the metal without harming the healthy cells around them.


International research collaboration reveals promising drug candidate for treatment of blood cancers

January 16, 2020

An international research collaboration between the United States and Australia has revealed a promising new drug which could treat high-risk leukaemia.

New therapy shows ‘dramatic’ effect against worst leukaemias

December 10, 2019

A collaborative research effort by Australian and US scientists has led to the discovery of a promising new approach to treating some of the worst types of leukaemia, including an aggressive leukaemia that mostly affects babies.

Researchers find new way to target childhood cancer

November 18, 2019

An Australian-led international research effort has broken fresh ground in the race to find more effective treatments for the childhood cancer neuroblastoma.

Children’s Cancer Institute welcome the Governor-General and Linda Hurley as Patrons

September 4, 2019

Children’s Cancer Institute is pleased to welcome His Excellency General the Honourable David Hurley AC DSC (Retd), Governor-General of Australia and Mrs Hurley as Patrons.

New gene found for a deadly childhood cancer offers possibility of targeted drug therapy

July 31, 2019

Australian researchers from Children’s Cancer Institute have discovered a gene that plays an important role in the childhood cancer neuroblastoma, and have developed a targeted therapy against it.

Australian researchers find chink in the armour of one of the most aggressive leukaemia types

July 28, 2019

A team from Children's Cancer Institute has found a drug that offers new hope to infants with one of the most aggressive forms of leukaemia.

New research paves the way for safer leukaemia treatments

May 30, 2019

An international team of researchers has discovered a new and much safer way to treat a type of leukaemia that mainly affects children: T-cell acute lymphoblastic leukemia (T-ALL).

Minderoo Foundation’s $5 million donation to Zero Childhood Cancer will help kids like Jack beat brain cancer

May 15, 2019

Today Minderoo Foundation’s Eliminate Cancer initiative announced a $5 million partnership with Zero to help scale the program in Australia, drive further research into personalised medicine in childhood cancer and help established standardised international protocols.

Childhood cancer scientist rewarded for research excellence

April 1, 2019

Children’s Cancer Institute researcher Professor Maria Kavallaris AM – who in January this year was appointed a Member of the Order of Australia for her significant service to medicine and to medical research – today received further recognition for her work, winning the prestigious Lemberg Medal.

Leading children’s cancer scientist awarded for outstanding research

March 15, 2019

Professor Murray Norris AM, Deputy Director of Children’s Cancer Institute and Director of the Centre for Childhood Cancer Research at the University of New South Wales, has won the inaugural Sally Crossing AM Award for an Outstanding Outcome in Cancer Research.

World-Class Comprehensive Children’s Cancer Centre Announced

March 1, 2019

State and Commonwealth Health Ministers, Brad Hazzard and Greg Hunt, announce that a new, world-class Comprehensive Children’s Cancer Centre will be built on the Randwick Hospital Campus, as a new home for Children’s Cancer Institute, and also for an expanded Kid’s Cancer Centre at Sydney Children’s Hospital.

Australian Scientists Discover a Potential Way to Treat and Prevent Cancer in Children with Neuroblastoma

February 1, 2019

In new research published this week, a team jointly led by Professors Michelle Haber and Murray Norris has revealed that the polyamine pathway is entirely regulated by the MYCN oncogene

Maria Kavallaris receives Order of Australia

January 26, 2019

Children’s Cancer Institute is thrilled to announce that Professor Maria Kavallaris – a leading childhood cancer researcher and a pioneer of nanomedicine in Australia – is to be appointed a Member of the Order of Australia. She will be included in the 2019 Australia Day Honours List for her significant service to medicine, and to medical research, in the field of childhood and adult cancers.

For children with the most common childhood cancer, resistance to treatment has remained an enigma – until now

December 17, 2018

Research published last week in the prestigious journal, Cancer Cell, by scientists at Children’s Cancer Institute in Sydney, has discovered why one of the most successful classes of drugs used to treat acute lymphoblastic leukaemia (ALL), glucocorticoids, fails to work in 15% of children with the disease.

How Targeting Copper Levels in Tumours Could Hold Key to One of the Deadliest Childhood Cancers

November 19, 2018

Tumour cells are known to have high levels of copper. Now researchers at Children’s Cancer Institute in Sydney have found that an antioxidant found in green tea can kill tumour cells by targeting only those with high levels of the metal without harming the healthy cells around them.


International research collaboration reveals promising drug candidate for treatment of blood cancers

January 16, 2020

An international research collaboration between the United States and Australia has revealed a promising new drug which could treat high-risk leukaemia.

New therapy shows ‘dramatic’ effect against worst leukaemias

December 10, 2019

A collaborative research effort by Australian and US scientists has led to the discovery of a promising new approach to treating some of the worst types of leukaemia, including an aggressive leukaemia that mostly affects babies.

Researchers find new way to target childhood cancer

November 18, 2019

An Australian-led international research effort has broken fresh ground in the race to find more effective treatments for the childhood cancer neuroblastoma.

Children’s Cancer Institute welcome the Governor-General and Linda Hurley as Patrons

September 4, 2019

Children’s Cancer Institute is pleased to welcome His Excellency General the Honourable David Hurley AC DSC (Retd), Governor-General of Australia and Mrs Hurley as Patrons.

New gene found for a deadly childhood cancer offers possibility of targeted drug therapy

July 31, 2019

Australian researchers from Children’s Cancer Institute have discovered a gene that plays an important role in the childhood cancer neuroblastoma, and have developed a targeted therapy against it.

Australian researchers find chink in the armour of one of the most aggressive leukaemia types

July 28, 2019

A team from Children's Cancer Institute has found a drug that offers new hope to infants with one of the most aggressive forms of leukaemia.

New research paves the way for safer leukaemia treatments

May 30, 2019

An international team of researchers has discovered a new and much safer way to treat a type of leukaemia that mainly affects children: T-cell acute lymphoblastic leukemia (T-ALL).

Minderoo Foundation’s $5 million donation to Zero Childhood Cancer will help kids like Jack beat brain cancer

May 15, 2019

Today Minderoo Foundation’s Eliminate Cancer initiative announced a $5 million partnership with Zero to help scale the program in Australia, drive further research into personalised medicine in childhood cancer and help established standardised international protocols.

Childhood cancer scientist rewarded for research excellence

April 1, 2019

Children’s Cancer Institute researcher Professor Maria Kavallaris AM – who in January this year was appointed a Member of the Order of Australia for her significant service to medicine and to medical research – today received further recognition for her work, winning the prestigious Lemberg Medal.

Leading children’s cancer scientist awarded for outstanding research

March 15, 2019

Professor Murray Norris AM, Deputy Director of Children’s Cancer Institute and Director of the Centre for Childhood Cancer Research at the University of New South Wales, has won the inaugural Sally Crossing AM Award for an Outstanding Outcome in Cancer Research.

World-Class Comprehensive Children’s Cancer Centre Announced

March 1, 2019

State and Commonwealth Health Ministers, Brad Hazzard and Greg Hunt, announce that a new, world-class Comprehensive Children’s Cancer Centre will be built on the Randwick Hospital Campus, as a new home for Children’s Cancer Institute, and also for an expanded Kid’s Cancer Centre at Sydney Children’s Hospital.

Australian Scientists Discover a Potential Way to Treat and Prevent Cancer in Children with Neuroblastoma

February 1, 2019

In new research published this week, a team jointly led by Professors Michelle Haber and Murray Norris has revealed that the polyamine pathway is entirely regulated by the MYCN oncogene

Maria Kavallaris receives Order of Australia

January 26, 2019

Children’s Cancer Institute is thrilled to announce that Professor Maria Kavallaris – a leading childhood cancer researcher and a pioneer of nanomedicine in Australia – is to be appointed a Member of the Order of Australia. She will be included in the 2019 Australia Day Honours List for her significant service to medicine, and to medical research, in the field of childhood and adult cancers.

For children with the most common childhood cancer, resistance to treatment has remained an enigma – until now

December 17, 2018

Research published last week in the prestigious journal, Cancer Cell, by scientists at Children’s Cancer Institute in Sydney, has discovered why one of the most successful classes of drugs used to treat acute lymphoblastic leukaemia (ALL), glucocorticoids, fails to work in 15% of children with the disease.

How Targeting Copper Levels in Tumours Could Hold Key to One of the Deadliest Childhood Cancers

November 19, 2018

Tumour cells are known to have high levels of copper. Now researchers at Children’s Cancer Institute in Sydney have found that an antioxidant found in green tea can kill tumour cells by targeting only those with high levels of the metal without harming the healthy cells around them.


International research collaboration reveals promising drug candidate for treatment of blood cancers

January 16, 2020

An international research collaboration between the United States and Australia has revealed a promising new drug which could treat high-risk leukaemia.

New therapy shows ‘dramatic’ effect against worst leukaemias

December 10, 2019

A collaborative research effort by Australian and US scientists has led to the discovery of a promising new approach to treating some of the worst types of leukaemia, including an aggressive leukaemia that mostly affects babies.

Researchers find new way to target childhood cancer

November 18, 2019

An Australian-led international research effort has broken fresh ground in the race to find more effective treatments for the childhood cancer neuroblastoma.

Children’s Cancer Institute welcome the Governor-General and Linda Hurley as Patrons

September 4, 2019

Children’s Cancer Institute is pleased to welcome His Excellency General the Honourable David Hurley AC DSC (Retd), Governor-General of Australia and Mrs Hurley as Patrons.

New gene found for a deadly childhood cancer offers possibility of targeted drug therapy

July 31, 2019

Australian researchers from Children’s Cancer Institute have discovered a gene that plays an important role in the childhood cancer neuroblastoma, and have developed a targeted therapy against it.

Australian researchers find chink in the armour of one of the most aggressive leukaemia types

July 28, 2019

A team from Children's Cancer Institute has found a drug that offers new hope to infants with one of the most aggressive forms of leukaemia.

New research paves the way for safer leukaemia treatments

May 30, 2019

An international team of researchers has discovered a new and much safer way to treat a type of leukaemia that mainly affects children: T-cell acute lymphoblastic leukemia (T-ALL).

Minderoo Foundation’s $5 million donation to Zero Childhood Cancer will help kids like Jack beat brain cancer

May 15, 2019

Today Minderoo Foundation’s Eliminate Cancer initiative announced a $5 million partnership with Zero to help scale the program in Australia, drive further research into personalised medicine in childhood cancer and help established standardised international protocols.

Childhood cancer scientist rewarded for research excellence

April 1, 2019

Children’s Cancer Institute researcher Professor Maria Kavallaris AM – who in January this year was appointed a Member of the Order of Australia for her significant service to medicine and to medical research – today received further recognition for her work, winning the prestigious Lemberg Medal.

Leading children’s cancer scientist awarded for outstanding research

March 15, 2019

Professor Murray Norris AM, Deputy Director of Children’s Cancer Institute and Director of the Centre for Childhood Cancer Research at the University of New South Wales, has won the inaugural Sally Crossing AM Award for an Outstanding Outcome in Cancer Research.

World-Class Comprehensive Children’s Cancer Centre Announced

March 1, 2019

State and Commonwealth Health Ministers, Brad Hazzard and Greg Hunt, announce that a new, world-class Comprehensive Children’s Cancer Centre will be built on the Randwick Hospital Campus, as a new home for Children’s Cancer Institute, and also for an expanded Kid’s Cancer Centre at Sydney Children’s Hospital.

Australian Scientists Discover a Potential Way to Treat and Prevent Cancer in Children with Neuroblastoma

February 1, 2019

In new research published this week, a team jointly led by Professors Michelle Haber and Murray Norris has revealed that the polyamine pathway is entirely regulated by the MYCN oncogene

Maria Kavallaris receives Order of Australia

January 26, 2019

Children’s Cancer Institute is thrilled to announce that Professor Maria Kavallaris – a leading childhood cancer researcher and a pioneer of nanomedicine in Australia – is to be appointed a Member of the Order of Australia. She will be included in the 2019 Australia Day Honours List for her significant service to medicine, and to medical research, in the field of childhood and adult cancers.

For children with the most common childhood cancer, resistance to treatment has remained an enigma – until now

December 17, 2018

Research published last week in the prestigious journal, Cancer Cell, by scientists at Children’s Cancer Institute in Sydney, has discovered why one of the most successful classes of drugs used to treat acute lymphoblastic leukaemia (ALL), glucocorticoids, fails to work in 15% of children with the disease.

How Targeting Copper Levels in Tumours Could Hold Key to One of the Deadliest Childhood Cancers

November 19, 2018

Tumour cells are known to have high levels of copper. Now researchers at Children’s Cancer Institute in Sydney have found that an antioxidant found in green tea can kill tumour cells by targeting only those with high levels of the metal without harming the healthy cells around them.


International research collaboration reveals promising drug candidate for treatment of blood cancers

January 16, 2020

An international research collaboration between the United States and Australia has revealed a promising new drug which could treat high-risk leukaemia.

New therapy shows ‘dramatic’ effect against worst leukaemias

December 10, 2019

A collaborative research effort by Australian and US scientists has led to the discovery of a promising new approach to treating some of the worst types of leukaemia, including an aggressive leukaemia that mostly affects babies.

Researchers find new way to target childhood cancer

November 18, 2019

An Australian-led international research effort has broken fresh ground in the race to find more effective treatments for the childhood cancer neuroblastoma.

Children’s Cancer Institute welcome the Governor-General and Linda Hurley as Patrons

September 4, 2019

Children’s Cancer Institute is pleased to welcome His Excellency General the Honourable David Hurley AC DSC (Retd), Governor-General of Australia and Mrs Hurley as Patrons.

New gene found for a deadly childhood cancer offers possibility of targeted drug therapy

July 31, 2019

Australian researchers from Children’s Cancer Institute have discovered a gene that plays an important role in the childhood cancer neuroblastoma, and have developed a targeted therapy against it.

Australian researchers find chink in the armour of one of the most aggressive leukaemia types

July 28, 2019

A team from Children's Cancer Institute has found a drug that offers new hope to infants with one of the most aggressive forms of leukaemia.

New research paves the way for safer leukaemia treatments

May 30, 2019

An international team of researchers has discovered a new and much safer way to treat a type of leukaemia that mainly affects children: T-cell acute lymphoblastic leukemia (T-ALL).

Minderoo Foundation’s $5 million donation to Zero Childhood Cancer will help kids like Jack beat brain cancer

May 15, 2019

Today Minderoo Foundation’s Eliminate Cancer initiative announced a $5 million partnership with Zero to help scale the program in Australia, drive further research into personalised medicine in childhood cancer and help established standardised international protocols.

Childhood cancer scientist rewarded for research excellence

April 1, 2019

Children’s Cancer Institute researcher Professor Maria Kavallaris AM – who in January this year was appointed a Member of the Order of Australia for her significant service to medicine and to medical research – today received further recognition for her work, winning the prestigious Lemberg Medal.

Leading children’s cancer scientist awarded for outstanding research

March 15, 2019

Professor Murray Norris AM, Deputy Director of Children’s Cancer Institute and Director of the Centre for Childhood Cancer Research at the University of New South Wales, has won the inaugural Sally Crossing AM Award for an Outstanding Outcome in Cancer Research.

World-Class Comprehensive Children’s Cancer Centre Announced

March 1, 2019

State and Commonwealth Health Ministers, Brad Hazzard and Greg Hunt, announce that a new, world-class Comprehensive Children’s Cancer Centre will be built on the Randwick Hospital Campus, as a new home for Children’s Cancer Institute, and also for an expanded Kid’s Cancer Centre at Sydney Children’s Hospital.

Australian Scientists Discover a Potential Way to Treat and Prevent Cancer in Children with Neuroblastoma

February 1, 2019

In new research published this week, a team jointly led by Professors Michelle Haber and Murray Norris has revealed that the polyamine pathway is entirely regulated by the MYCN oncogene

Maria Kavallaris receives Order of Australia

January 26, 2019

Children’s Cancer Institute is thrilled to announce that Professor Maria Kavallaris – a leading childhood cancer researcher and a pioneer of nanomedicine in Australia – is to be appointed a Member of the Order of Australia. She will be included in the 2019 Australia Day Honours List for her significant service to medicine, and to medical research, in the field of childhood and adult cancers.

For children with the most common childhood cancer, resistance to treatment has remained an enigma – until now

December 17, 2018

Research published last week in the prestigious journal, Cancer Cell, by scientists at Children’s Cancer Institute in Sydney, has discovered why one of the most successful classes of drugs used to treat acute lymphoblastic leukaemia (ALL), glucocorticoids, fails to work in 15% of children with the disease.

How Targeting Copper Levels in Tumours Could Hold Key to One of the Deadliest Childhood Cancers

November 19, 2018

Tumour cells are known to have high levels of copper. Now researchers at Children’s Cancer Institute in Sydney have found that an antioxidant found in green tea can kill tumour cells by targeting only those with high levels of the metal without harming the healthy cells around them.


International research collaboration reveals promising drug candidate for treatment of blood cancers

January 16, 2020

An international research collaboration between the United States and Australia has revealed a promising new drug which could treat high-risk leukaemia.

New therapy shows ‘dramatic’ effect against worst leukaemias

December 10, 2019

A collaborative research effort by Australian and US scientists has led to the discovery of a promising new approach to treating some of the worst types of leukaemia, including an aggressive leukaemia that mostly affects babies.

Researchers find new way to target childhood cancer

November 18, 2019

An Australian-led international research effort has broken fresh ground in the race to find more effective treatments for the childhood cancer neuroblastoma.

Children’s Cancer Institute welcome the Governor-General and Linda Hurley as Patrons

September 4, 2019

Children’s Cancer Institute is pleased to welcome His Excellency General the Honourable David Hurley AC DSC (Retd), Governor-General of Australia and Mrs Hurley as Patrons.

New gene found for a deadly childhood cancer offers possibility of targeted drug therapy

July 31, 2019

Australian researchers from Children’s Cancer Institute have discovered a gene that plays an important role in the childhood cancer neuroblastoma, and have developed a targeted therapy against it.

Australian researchers find chink in the armour of one of the most aggressive leukaemia types

July 28, 2019

A team from Children's Cancer Institute has found a drug that offers new hope to infants with one of the most aggressive forms of leukaemia.

New research paves the way for safer leukaemia treatments

May 30, 2019

An international team of researchers has discovered a new and much safer way to treat a type of leukaemia that mainly affects children: T-cell acute lymphoblastic leukemia (T-ALL).

Minderoo Foundation’s $5 million donation to Zero Childhood Cancer will help kids like Jack beat brain cancer

May 15, 2019

Today Minderoo Foundation’s Eliminate Cancer initiative announced a $5 million partnership with Zero to help scale the program in Australia, drive further research into personalised medicine in childhood cancer and help established standardised international protocols.

Childhood cancer scientist rewarded for research excellence

April 1, 2019

Children’s Cancer Institute researcher Professor Maria Kavallaris AM – who in January this year was appointed a Member of the Order of Australia for her significant service to medicine and to medical research – today received further recognition for her work, winning the prestigious Lemberg Medal.

Leading children’s cancer scientist awarded for outstanding research

March 15, 2019

Professor Murray Norris AM, Deputy Director of Children’s Cancer Institute and Director of the Centre for Childhood Cancer Research at the University of New South Wales, has won the inaugural Sally Crossing AM Award for an Outstanding Outcome in Cancer Research.

World-Class Comprehensive Children’s Cancer Centre Announced

March 1, 2019

State and Commonwealth Health Ministers, Brad Hazzard and Greg Hunt, announce that a new, world-class Comprehensive Children’s Cancer Centre will be built on the Randwick Hospital Campus, as a new home for Children’s Cancer Institute, and also for an expanded Kid’s Cancer Centre at Sydney Children’s Hospital.

Australian Scientists Discover a Potential Way to Treat and Prevent Cancer in Children with Neuroblastoma

February 1, 2019

In new research published this week, a team jointly led by Professors Michelle Haber and Murray Norris has revealed that the polyamine pathway is entirely regulated by the MYCN oncogene

Maria Kavallaris receives Order of Australia

January 26, 2019

Children’s Cancer Institute is thrilled to announce that Professor Maria Kavallaris – a leading childhood cancer researcher and a pioneer of nanomedicine in Australia – is to be appointed a Member of the Order of Australia. She will be included in the 2019 Australia Day Honours List for her significant service to medicine, and to medical research, in the field of childhood and adult cancers.

For children with the most common childhood cancer, resistance to treatment has remained an enigma – until now

December 17, 2018

Research published last week in the prestigious journal, Cancer Cell, by scientists at Children’s Cancer Institute in Sydney, has discovered why one of the most successful classes of drugs used to treat acute lymphoblastic leukaemia (ALL), glucocorticoids, fails to work in 15% of children with the disease.

How Targeting Copper Levels in Tumours Could Hold Key to One of the Deadliest Childhood Cancers

November 19, 2018

Tumour cells are known to have high levels of copper. Now researchers at Children’s Cancer Institute in Sydney have found that an antioxidant found in green tea can kill tumour cells by targeting only those with high levels of the metal without harming the healthy cells around them.